Cost-Per-Responder Analysis for Tralokinumab and Dupilumab in Combination with Topical Corticosteroids in Patients with Moderate-To-Severe Atopic Dermatitis
Authors
Liv Strømkjær
M. Benvenuto (ORCID: https://orcid.org/0000-0003-4643-670X)
A Petersen (ORCID: https://orcid.org/0000-0001-7286-5239)
Cost-Per-Responder Analysis for Tralokinumab and Dupilumab in Combination with Topical Corticosteroids in Patients with Moderate-To-Severe Atopic Dermatitis
Liv Strømkjær, M. Benvenuto, A Petersen, Marni Wiseman et al.
Journal
Dermatology and Therapy
Topics
Dermatology and Skin Diseases
article
Cost-Per-Responder Analysis for Tralokinumab and Dupilumab in Combination with Topical Corticosteroids in Patients with Moderate-To-Severe Atopic Dermatitis
Liv Strømkjær, M. Benvenuto, A Petersen, Marni Wiseman, Lasse Ryttig, Andreas Wollenberg, Asger Sand Paludan‐Müller
article en
Abstract
No abstract available for this paper.
Publication Tag
Dermatology and TherapyVol. 16(1)
Institutions
University of Salento (IT), University Hospital Augsburg (DE), World Islamic Sciences and Education University (JO), SKiN Health (CA), Leo Pharma (Denmark) (DK), Ludwig-Maximilians-Universität München (DE), University of Lübeck (DE), Nelson Mandela University (ZA)